<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clinics (Sao Paulo)</journal-id><journal-id journal-id-type="iso-abbrev">Clinics (Sao Paulo)</journal-id><journal-title-group><journal-title>Clinics</journal-title></journal-title-group><issn pub-type="ppub">1807-5932</issn><issn pub-type="epub">1980-5322</issn><publisher><publisher-name>Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25141110</article-id><article-id pub-id-type="pmc">4129559</article-id><article-id pub-id-type="doi">10.6061/clinics/2014(08)04</article-id><article-id pub-id-type="publisher-id">cln_69p524</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Science</subject></subj-group></article-categories><title-group><article-title>Effects of placebo-controlled continuous and pulsed ultrasound treatments on carpal tunnel syndrome: a randomized trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Armagan</surname><given-names>Onur</given-names></name><xref ref-type="aff" rid="af1-cln_69p524">I</xref></contrib><contrib contrib-type="author"><name><surname>Bakilan</surname><given-names>Fulya</given-names></name><xref ref-type="aff" rid="af1-cln_69p524">I</xref></contrib><contrib contrib-type="author"><name><surname>Ozgen</surname><given-names>Merih</given-names></name><xref ref-type="aff" rid="af1-cln_69p524">I</xref></contrib><contrib contrib-type="author"><name><surname>Mehmetoglu</surname><given-names>Ozlem</given-names></name><xref ref-type="aff" rid="af2-cln_69p524">II</xref></contrib><contrib contrib-type="author"><name><surname>Oner</surname><given-names>Setenay</given-names></name><xref ref-type="aff" rid="af3-cln_69p524">III</xref></contrib><aff id="af1-cln_69p524"><label>I</label>Eskisehir Osmangazi University Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Eskisehir, Turkey.</aff><aff id="af2-cln_69p524"><label>II</label>Konya State Hospital, Department of Physical Medicine and Rehabilitation, Eregli, Turkey.</aff><aff id="af3-cln_69p524"><label>III</label>Eskisehir Osmangazi University University Faculty of Medicine, Department of Biostatistics, Eskisehir, Turkey.</aff></contrib-group><author-notes><fn fn-type="con"><p>Armagan O was the study director. Bakilan F, Ozgen M and Mehmetoglu O were the assistant directors. Oner S was the co-assistant for the statistical analyses.</p></fn><corresp id="c1-cln_69p524">E-mail: <email>dronurarmagan@hotmail.com</email> Tel.: <phone>+90 222 2392979/2457</phone></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2014</year></pub-date><volume>69</volume><issue>8</issue><fpage>524</fpage><lpage>528</lpage><history><date date-type="received"><day>24</day><month>1</month><year>2014</year></date><date date-type="rev-recd"><day>21</day><month>2</month><year>2014</year></date><date date-type="accepted"><day>21</day><month>2</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Hospital das Cl&#x000ed;nicas da FMUSP</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>OBJECTIVE:</title><p>The aim of this placebo-controlled study was to evaluate the effects of pulsed and continuous ultrasound treatments combined with splint therapy on patients with mild and moderate idiopathic carpal tunnel syndrome.</p></sec><sec><title>METHODS:</title><p>The study included 46 carpal tunnel syndrome patients who were randomly divided into 3 groups. The first group (n&#x0200a;=&#x0200a;15) received a 0 W/cm<sup>2</sup> ultrasound treatment (placebo); the second group (n&#x0200a;=&#x0200a;16) received a 1.0 W/cm<sup>2</sup> continuous ultrasound treatment and the third group (n&#x0200a;=&#x0200a;15) received a 1.0 W/cm<sup>2</sup> 1:4 pulsed ultrasound treatment 5 days a week for a total of 15 sessions. All patients also wore night splints during treatment period. Pre-treatment and post-treatment Visual Analogue Scale, Symptom Severity Scale and Functional Status Scale scores, median nerve motor conduction velocity and distal latency and sensory conduction velocities of the median nerve in the 2<sup>nd</sup> finger and palm were compared. Clinicaltrials.gov: NCT02054247.</p></sec><sec><title>RESULTS:</title><p>There were significant improvements in all groups in terms of the post-treatment Functional Status Scale score (<italic>p</italic>&#x0003c;0.05 for all groups), Symptom Severity Scale score (first group: <italic>p</italic>&#x0003c;0.05, second group: <italic>p</italic>&#x0003c;0.01, third group: <italic>p</italic>&#x0003c;0.001) and Visual Analogue Scale score (first and third groups: <italic>p</italic>&#x0003c;0.01, second group: <italic>p</italic>&#x0003c;0.001). Sensory conduction velocities improved in the second and third groups (<italic>p</italic>&#x0003c;0.01). Distal latency in the 2<sup>nd</sup> finger showed improvement only in the third group (<italic>p</italic>&#x0003c;0.01) and action potential latency in the palm improved only in the second group (<italic>p</italic>&#x0003c;0.05).</p></sec><sec><title>CONCLUSION:</title><p>The results of this study suggest that splinting therapy combined with placebo and pulsed or continuous ultrasound have similar effects on clinical improvement. Patients treated with continuous and pulsed ultrasound showed electrophysiological improvement; however, the results were not superior to those of the placebo.</p></sec></abstract><kwd-group><kwd>Carpal Tunnel Syndrome</kwd><kwd>Continuous Ultrasound</kwd><kwd>Pulsed Ultrasound</kwd></kwd-group><counts><page-count count="5"/></counts></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Carpal tunnel syndrome (CTS) is an entrapment mononeuropathy that is commonly observed in clinical practice and is caused by the compression of the median nerve at the wrist (<xref rid="b1-cln_69p524" ref-type="bibr">1</xref>). When the median nerve is compressed in the tunnel, the patient develops the signs and symptoms of CTS. The most common symptoms of CTS include pain, paresthesia, numbness or tingling involving the fingers that are innervated by the median nerve and a weakness of thumb abduction. The symptoms are at their worst at night and often wake the patient (<xref rid="b2-cln_69p524" ref-type="bibr">2</xref>).</p><p>Both conservative and surgical treatments are used to relieve the pressure on the median nerve (<xref rid="b1-cln_69p524" ref-type="bibr">1</xref>). The choice between conservative and surgical treatment is determined by the severity of the symptoms and the patient's physical limitations (<xref rid="b3-cln_69p524" ref-type="bibr">3</xref>).</p><p>Conservative treatment of CTS would seem to be preferable as the initial treatment choice, particularly for mild to moderate cases (<xref rid="b1-cln_69p524" ref-type="bibr">1</xref>). However, the efficacy of conservative treatment options for CTS is controversial (<xref rid="b1-cln_69p524" ref-type="bibr">1</xref>). Ultrasound (US) is a widely used and accepted adjunct modality for the management of many musculoskeletal conditions (<xref rid="b4-cln_69p524" ref-type="bibr">4</xref>). US converts electrical energy into an acoustic waveform, which is then converted into heat as it passes through tissues of varying resistance (<xref rid="b5-cln_69p524" ref-type="bibr">5</xref>). Therapeutic US is reported to reduce edema, relieve pain and accelerate tissue repair (<xref rid="b6-cln_69p524" ref-type="bibr">6</xref>-<xref rid="b8-cln_69p524" ref-type="bibr">8</xref>). The exact mechanism of action of therapeutic US remains to be elucidated, although it is used to treat various musculoskeletal disorders. Analgesia that is induced by therapeutic US may be the result of increased capillary permeability and tissue metabolism, the enhancement of fibrous tissue extensibility and the elevation of the pain threshold by thermal mechanisms (<xref rid="b6-cln_69p524" ref-type="bibr">6</xref>,<xref rid="b9-cln_69p524" ref-type="bibr">9</xref>). Therapeutic US can be applied as pulsed or continuous therapy.</p><p>Only a few studies have reported the benefits of therapeutic US in CTS patients and there are conflicting results on its efficacy in the treatment of CTS (<xref rid="b1-cln_69p524" ref-type="bibr">1</xref>,<xref rid="b10-cln_69p524" ref-type="bibr">10</xref>,<xref rid="b11-cln_69p524" ref-type="bibr">11</xref>). Recently, the effectiveness of pulsed and continuous US therapy was compared with a placebo and the authors reported satisfactory effects in patients with mild to moderate CTS (<xref rid="b10-cln_69p524" ref-type="bibr">10</xref>,<xref rid="b12-cln_69p524" ref-type="bibr">12</xref>,<xref rid="b13-cln_69p524" ref-type="bibr">13</xref>).</p><p>Splinting is the most popular method among the conservative treatments that are available for CTS (<xref rid="b13-cln_69p524" ref-type="bibr">13</xref>-<xref rid="b15-cln_69p524" ref-type="bibr">15</xref>). Immobilization of the wrist in a neutral position with a splint maximizes the carpal tunnel volume and minimizes the pressure on the median nerve (<xref rid="b1-cln_69p524" ref-type="bibr">1</xref>).</p><p>The aim of this study was to evaluate the effects of pulsed and continuous US treatments in combination with splint therapy on patients with mild and moderate idiopathic CTS compared to a placebo.</p></sec><sec sec-type="methods"><title>METHODS</title><p>The study was carried out at the outpatient clinic of the Eskisehir Osmangazi University Faculty of Medicine, Department of Physical Medicine and Rehabilitation between October 2011 and January 2013. A total of 36 female patients with clinical and electrophysiological evidence of mild or moderate idiopathic CTS (without thenar atrophy or spontaneous activity as determined by the electrophysiological examination of the abductor pollicis brevis (APB) muscle) were included in the study. All of the patients had unilateral CTS and were right-handed.</p><p>Patients were excluded if they had secondary entrapment neuropathies, cervical radiculopathy or systemic diseases that are associated with increased CTS risk in addition to those who had undergone surgery for the syndrome, had been treated with US or had a history of steroid injections into the carpal tunnel and physical therapy within the last 3 months. Additionally, patients with either thenar atrophy or spontaneous activity (fibrillation potentials and positive sharp waves) as determined by an electrophysiological examination of the APB muscle were excluded from the study.</p><sec><title>Study design</title><p>This study was designed as a prospective, randomized, placebo-controlled, double-blind study. All of the patients were assessed by the same physiatrist before beginning treatment and at the end of the three weeks of treatment. Before initiation and after the three weeks, all of the patients were assessed by the same physiatrist. Neither the investigator nor the patients were informed of the treatment assignments. The study was conducted in full compliance with the amended Declaration of Helsinki after obtaining approval from the institutional review board of Eskisehir Osmangazi University (date/n&#x000b0;: 18-05-2012/127). Following baseline assessments, the patients who fulfilled the inclusion criteria and were included in the study were randomly assigned to one of three groups using a secure system of opaque closed envelopes that were numbered from 1 to 3.</p><p>Forty-six patients were randomly assigned to one of the three groups: group 1 (n&#x0200a;=&#x0200a;15) received splinting and continuous US therapy; group 2 (n&#x0200a;=&#x0200a;16) received splinting and pulsed US therapy and group 3 (n&#x0200a;=&#x0200a;15) received splinting and a &#x02018;sham' (placebo) US therapy.</p></sec><sec><title>Treatment protocol</title><p>Custom-made neutral volar splints were given to all of the patients that were included in the study. They were instructed to wear the splints at night and during the day for a total of three weeks.</p><p>Continuous, pulsed and sham US therapies were performed on all of the patients by the same physiotherapist. In group 1 (continuous US group), US treatments were administered to the carpal tunnel area at a frequency of 1 with an intensity of 1 W/cm<sup>2</sup> and a transducer of 5 cm<sup>2</sup> in size (Sonopuls 434; Enraf Nonius, Delft, The Netherlands), using aquasonic gel that did not contain any pharmacologically active substances. The apparatus was initially standardized and the output was controlled by a simple underwater radiation balance.</p><p>In group 2 (pulsed US group), the same US equipment was set at a frequency of 1 MHz with an intensity of 1 W/cm<sup>2</sup> and a pulsed mode duty cycle of 1:4. The duration of the applied US and the posture of the patient being treated were the same as those that were described for the continuous US group. The patients in group 3 (placebo US group) received a &#x02018;sham' US application wherein the US device that was described above appeared to be working but did not deliver any output. US treatment sessions were performed once a day, five days a week, for a total of three weeks.</p></sec><sec><title>Evaluations</title><p>All of the patients were evaluated immediately before and after the three-week treatment by a blinded investigator with respect to the parameters that are described below.</p></sec><sec><title>Electrophysiological evaluations</title><p>Electrophysiological evaluations were performed at baseline and at the end of the treatment. Using standard techniques, all of the electrodiagnostic tests were performed by the same physician using a Medelec Sapphire 4 ME (Medelec, Old Woking, UK) electromyography apparatus. The hands of each patient were warmed prior to testing by seating them for 15 minutes in an examining room at a temperature of 22-24&#x000b0;C. To evaluate the median nerve, motor distal latency (DL), motor nerve conduction velocity (NCV), sensory DL and palm-wrist sensory NCV measurements were measured in all patients. Surface stimulation and recording electrodes were used for the sensory and NCV tests employing standard methodology (<xref rid="b16-cln_69p524" ref-type="bibr">16</xref>). The compound muscle action potentials of the abductor pollicis brevis muscle that were induced by supramaximal electrical stimulation on the median nerve at the wrist 8 cm from the recording electrode were recorded. DL and NCV studies were performed from the wrist to the APB muscle at a distance of 8 cm. For the sensory nerve conduction studies, the median sensory fibers were stimulated antidromically at the midpalm and wrist at distances of 7 cm and 14 cm from the recording ring electrode that was looped around the proximal interphalangeal joint of the third digit. The onset latencies of the negative potentials were taken into consideration. For sensory testing, the sweep-speed velocity was set at 10 msec, whereas for motor testing, it was set at 30 msec; the duration of the stimulus was 0.1 msec in both studies. The voltage was increased until the action potentials reached maximal amplitude. The main electrophysiological criteria for the diagnosis of CTS were the slowing of sensory nerve conduction velocity of the median nerve in the palm-wrist segment or an absence of sensory nerve action potential of the median nerve that was accompanied by prolonged terminal motor latency (<xref rid="b17-cln_69p524" ref-type="bibr">17</xref>). In our electrophysiology laboratory, if the median nerve DL was 3.9 msn or above, the median nerve sensory latency was 3 msn or above and the sensory nerve conduction velocity of the median nerve in the palm-wrist segment was 35.2 m/sn or below, the subjects were considered to have CTS.</p></sec><sec><title>Clinical assessment</title><p>A blinded physician who was unaware of the treatment allocations performed the clinical assessments at baseline and at the end of the treatments. Symptom Severity scores (SSSs), Functional Status scores (FSSs) and a Visual Analog Scale (VAS) were used for the clinical follow-up and evaluation of the patients.</p><p>The severity of the pain was assessed using a VAS consisting of 10-cm horizontal lines with anchor points of 0 (no pain) and 10 (maximum pain). The Symptom Severity Scale has 11 items in relation to pain, including nocturnal symptoms, numbness, tingling and weakness (<xref rid="b18-cln_69p524" ref-type="bibr">18</xref>). The Functional Status Scale encompasses 8 items (difficulty in writing, buttoning clothes, opening jars, holding a book, gripping a telephone handle, performing household chores, carrying grocery bags, bathing and dressing). Each item in these scales has five ordinal response categories, ranging from 1 (no symptoms or no difficulty) to 5 (severe symptoms).</p></sec><sec><title>Statistical analyses</title><p>Statistical analyses were performed using SPSS 18.0 for Windows. The normality of the distribution of the data was confirmed by the Kolmogorov-Smirnov test. The results were analyzed by a one-way ANOVA with post-hoc Tukey HSD tests and t-tests. The results were reported as the mean&#x000b1;SD. Power calculations were evaluated using a one-way ANOVA and the power of the study was 0.70 (70%). The significance level was set at <italic>p</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p><xref ref-type="table" rid="t1-cln_69p524">Table&#x000a0;1</xref>) shows the demographic characteristics of the study groups. No significant differences were observed between the groups. There were significant improvements in all groups for all clinical parameters. There were no significant differences between the groups (<xref ref-type="table" rid="t2-cln_69p524">Table&#x000a0;2</xref>).</p><p><xref ref-type="table" rid="t3-cln_69p524">Table&#x000a0;3</xref>) shows a comparison of the electrophysiological measurements that were obtained before and after the treatments. The sensory conduction velocity of the median nerve showed improvement in the second and third groups, the sensory DL of the median nerve (digit II to palm) improved only in the third group, and the sensory DL of the median nerve (palm to wrist) improved only in the second group. There were no significant differences between the groups.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>CTS is one of the most common hand disorders. The highest incidence is among middle-aged and elderly women (<xref rid="b19-cln_69p524" ref-type="bibr">19</xref>). Although several treatment modalities are routinely used, there is no consensus regarding the best way to manage CTS. The aim of this placebo-controlled study was to evaluate the effects of pulsed and continuous US treatments in combination with splinting therapy on various clinical and electrophysiological parameters in patients with CTS.</p><p>Splinting is the most popular method among the conservative treatment modalities that are available for CTS (<xref rid="b14-cln_69p524" ref-type="bibr">14</xref>,<xref rid="b15-cln_69p524" ref-type="bibr">15</xref>). The efficacy of wrist splinting therapy has been variably demonstrated in several studies (<xref rid="b15-cln_69p524" ref-type="bibr">15</xref>,<xref rid="b20-cln_69p524" ref-type="bibr">20</xref>,<xref rid="b21-cln_69p524" ref-type="bibr">21</xref>). Premoselli et al. reported that splinting therapy improved symptoms and electrophysiological parameters in CTS patients (<xref rid="b21-cln_69p524" ref-type="bibr">21</xref>).</p><p>In our study, a night rest splint was used by all of the participants and clinical improvement was observed in all of the groups. Placebo US can lead to symptom relief by producing a local massage effect; however, this symptomatic improvement may be, in fact, related to the splinting therapy, as has been observed in recent studies investigating the beneficial effects of splinting therapy in CTS. Electrophysiological improvement was found in the continuous and pulsed US groups but not in the placebo group.</p><p>US is used extensively in musculoskeletal disorders. A few studies have found US therapy to be effective for CTS (<xref rid="b10-cln_69p524" ref-type="bibr">10</xref>,<xref rid="b12-cln_69p524" ref-type="bibr">12</xref>,<xref rid="b13-cln_69p524" ref-type="bibr">13</xref>). However, a consensus has yet to be reached regarding the optimal therapeutic US parameters (intensity, frequency of sound waves, duration, pulse, etc.) (<xref rid="b1-cln_69p524" ref-type="bibr">1</xref>,<xref rid="b10-cln_69p524" ref-type="bibr">10</xref>,<xref rid="b13-cln_69p524" ref-type="bibr">13</xref>,<xref rid="b22-cln_69p524" ref-type="bibr">22</xref>).</p><p>Therapeutic US can be applied in a pulsed or continuous manner. Pulsed US has been recommended for acute pain and inflammation, whereas continuous US has been recommended for the treatment of restricted movement (<xref rid="b23-cln_69p524" ref-type="bibr">23</xref>). Pulsed US produces non-thermal effects and is used to aid in the reduction of inflammation, whereas continuous US generates thermal effects (<xref rid="b6-cln_69p524" ref-type="bibr">6</xref>).</p><p>The aim of this study was to compare the effects of pulsed and continuous US treatments on patients with CTS. In the placebo-controlled study that was conducted by Ebenbichler et al., the US method was similar to that which was used in our study with the exception of the therapy time (1 MHz, 1.0 W/cm<sup>2</sup> in pulsed mode 1:4 for 15 min per session). This group revealed the clinical and electrophysiological improvement of CTS symptoms (<xref rid="b10-cln_69p524" ref-type="bibr">10</xref>). In another study comparing the efficiency of US and laser therapy, US (1 MHz, 1.0 W/cm<sup>2</sup> in pulsed mode 1:4 for 15 min per session) was found to be more effective than laser therapy for CTS in terms of electrophysiological parameters (<xref rid="b22-cln_69p524" ref-type="bibr">22</xref>). US therapy in combination with splinting therapy was compared with ketoprofen phonophoresis in a placebo-controlled study and the electrophysiological and clinical parameters were reported to improve in both groups (<xref rid="b24-cln_69p524" ref-type="bibr">24</xref>). Electrophysiological and clinical improvements were observed in our study in the pulsed US group. These results are in agreement with those from other studies, although there are some methodological differences.</p><p>In the group that received continuous US therapy in combination with splinting therapy, the treatment was applied for 10 min per session to the carpal tunnel area at a frequency of 1 and an intensity of 1 W/cm<sup>2</sup>. The efficacy of continuous US in CTS has been previously evaluated in only a few studies (<xref rid="b12-cln_69p524" ref-type="bibr">12</xref>,<xref rid="b25-cln_69p524" ref-type="bibr">25</xref>,<xref rid="b26-cln_69p524" ref-type="bibr">26</xref>). A placebo-controlled study reported clinical and electrophysiological improvement using different doses of US therapy (1.5 W/cm<sup>2</sup>, 0.8 W/cm<sup>2</sup>, 0 W/cm<sup>2</sup>). In addition, the NCV decreased slightly and DL increased in the US group (<xref rid="b13-cln_69p524" ref-type="bibr">13</xref>). In a placebo-controlled study evaluating low-intensity (0.5 W/cm<sup>2</sup>) US, a significant improvement in clinical variables was observed after the treatment, although there were no differences in the electrophysiological variables (<xref rid="b12-cln_69p524" ref-type="bibr">12</xref>). In another placebo-controlled study, clinical improvement was observed with US therapy (1.5 W/cm<sup>2</sup>); however, no electrophysiological improvement was found (<xref rid="b25-cln_69p524" ref-type="bibr">25</xref>).</p><p>Because the US intensities that were used differ in all of these studies, it is difficult to compare results. Furthermore, there is no consensus in the literature regarding the effective dose for US therapy. Similarly to our study, Dincer et al. compared splinting therapy alone with continuous US therapy (at an intensity of 1.0 W/cm<sup>2</sup>) combined with splinting therapy in addition to laser therapy combined with splinting therapy and found clinical and electrophysiological improvement in the combined therapy groups (<xref rid="b26-cln_69p524" ref-type="bibr">26</xref>).</p><p>US is assumed to be an anti-inflammatory procedure that increases blood flow, local metabolism and tissue regeneration in target tissues in addition to reducing edema and pain and limiting nerve compression (<xref rid="b1-cln_69p524" ref-type="bibr">1</xref>).</p><p>Evidence of an anti-inflammatory effect of US treatment from experiments on the stimulation of nerve regeneration and on nerve conduction supports the idea that US treatment may facilitate recovery from nerve compression (<xref rid="b27-cln_69p524" ref-type="bibr">27</xref>-<xref rid="b30-cln_69p524" ref-type="bibr">30</xref>).</p><p>In our study, the patients that were treated with pulsed and continuous US showed electrophysiological improvement; however, these results were not superior to those that were observed with the placebo. We believe that this electrophysiological improvement is related to the mechanism of action of the US therapy. Further, the lack of intergroup differences in the electrophysiological parameters may be related to the small sample size.</p><p>There are no studies currently available comparing the effects of continuous and pulsed US. The relatively small number of patients and lack of data describing a long-term follow-up of the patients were the main limitations of our study.</p><p>In our study, splinting therapy in combination with pulsed or continuous US or placebo showed similar clinical results. Patients who were treated with continuous and pulsed US showed electrophysiological improvement; however, the results that were obtained, were not superior to those that were reported with the placebo. There is still no existing consensus on optimal therapeutic US parameters and well-designed studies with long-term follow-up are needed.</p></sec></body><back><fn-group><fn fn-type="conflict"><p>No potential conflict of interest was reported.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-cln_69p524"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerritsen</surname><given-names>AA</given-names></name><name><surname>de Krom</surname><given-names>MC</given-names></name><name><surname>Struijs</surname><given-names>MA</given-names></name><name><surname>Scholten</surname><given-names>RJ</given-names></name><name><surname>de Vet</surname><given-names>HC</given-names></name><name><surname>Bouter</surname><given-names>LM</given-names></name></person-group><article-title>Conservative treatment options for carpal tunnel syndrome: a systematic review of randomised controlled trials</article-title><source>J&#x000a0;Neurol</source><year>2002</year><volume>249(3)</volume><fpage>272</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">11993525</pub-id></element-citation></ref><ref id="b2-cln_69p524"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simovic</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>DH</given-names></name></person-group><article-title>Carpal tunnel syndrome</article-title><source>Archives of Neurology</source><year>2000</year><volume>57(5)</volume><fpage>754</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">10815148</pub-id></element-citation></ref><ref id="b3-cln_69p524"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patijn</surname><given-names>J</given-names></name><name><surname>Vallejo</surname><given-names>R</given-names></name><name><surname>Janssen</surname><given-names>M</given-names></name><name><surname>Huygen</surname><given-names>F</given-names></name><name><surname>Lataster</surname><given-names>A</given-names></name><name><surname>van Kleef</surname><given-names>M</given-names></name><etal/></person-group><article-title>Carpal tunnel syndrome Pain Pract</article-title><year>2011</year><volume>11(3)</volume><fpage>297</fpage><lpage>301</lpage></element-citation></ref><ref id="b4-cln_69p524"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wong</surname><given-names>RA</given-names></name><name><surname>Schumann</surname><given-names>B</given-names></name><name><surname>Townsend</surname><given-names>R</given-names></name><name><surname>Phelps</surname><given-names>CA</given-names></name></person-group><article-title>A survey of therapeutic ultrasound use by physical therapists who are orthopaedic certified specialists</article-title><source>Phys Ther</source><year>2007</year><volume>87(8)</volume><fpage>986</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">17553923</pub-id></element-citation></ref><ref id="b5-cln_69p524"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klaiman</surname><given-names>MD</given-names></name><name><surname>Shrader</surname><given-names>JA</given-names></name><name><surname>Danoff</surname><given-names>JV</given-names></name><name><surname>Hicks</surname><given-names>JE</given-names></name><name><surname>Pesce</surname><given-names>WJ</given-names></name><name><surname>Ferland</surname><given-names>J</given-names></name></person-group><article-title>Phonophoresis versus ultrasound in the treatment of common musculoskeletal conditions</article-title><source>Med Sci Sports Exerc</source><year>1998</year><volume>30(9)</volume><fpage>1349</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">9741602</pub-id></element-citation></ref><ref id="b6-cln_69p524"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rutjes</surname><given-names>AW</given-names></name><name><surname>N&#x000fc;esch</surname><given-names>E</given-names></name><name><surname>Sterchi</surname><given-names>R</given-names></name><name><surname>J&#x000fc;ni</surname><given-names>P</given-names></name></person-group><article-title>Therapeutic ultrasound for osteoarthritis of the knee or hip</article-title><source>Cochrane Database Syst Rev</source><year>2010</year><volume>20(1)</volume><fpage>CD003132</fpage><pub-id pub-id-type="pmid">20091539</pub-id></element-citation></ref><ref id="b7-cln_69p524"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fu</surname><given-names>SC</given-names></name><name><surname>Shum</surname><given-names>WT</given-names></name><name><surname>Hung</surname><given-names>LK</given-names></name><name><surname>Wong</surname><given-names>MW</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Chan</surname><given-names>KM</given-names></name></person-group><article-title>Low-intensity pulsed ultrasound on tendon healing: a study of the effect of treatment duration and treatment initiation</article-title><source>Am&#x000a0;J&#x000a0;Sports Med</source><year>2008</year><volume>36(9)</volume><fpage>1742</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18645043</pub-id></element-citation></ref><ref id="b8-cln_69p524"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Korstjens</surname><given-names>CM</given-names></name><name><surname>van der Rijt</surname><given-names>RH</given-names></name><name><surname>Albers</surname><given-names>GH</given-names></name><name><surname>Semeins</surname><given-names>CM</given-names></name><name><surname>Klein-Nulend</surname><given-names>J</given-names></name></person-group><article-title>Low-intensity pulsed ultrasound affects human articular chondrocytes in vitro</article-title><source>Med Biol Eng Comput</source><year>2008</year><volume>46(12)</volume><fpage>1263</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">18853213</pub-id></element-citation></ref><ref id="b9-cln_69p524"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baker</surname><given-names>KG</given-names></name><name><surname>Robertson</surname><given-names>VJ</given-names></name><name><surname>Duck</surname><given-names>FA</given-names></name></person-group><article-title>A review of therapeutic ultrasound: biophysical effects</article-title><source>Phys Ther</source><year>2001</year><volume>81(7)</volume><fpage>1351</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11444998</pub-id></element-citation></ref><ref id="b10-cln_69p524"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ebenbichler</surname><given-names>GR</given-names></name><name><surname>Resch</surname><given-names>KL</given-names></name><name><surname>Nicolakis</surname><given-names>P</given-names></name><name><surname>Wiesinger</surname><given-names>GF</given-names></name><name><surname>Uhl</surname><given-names>F</given-names></name><name><surname>Ghanem</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Ultrasound treatment for treating the carpal tunnel syndrome: randomised "sham" controlled trial</article-title><source>BMJ</source><year>1998</year><volume>7;316(7133)</volume><fpage>731</fpage><lpage>5</lpage></element-citation></ref><ref id="b11-cln_69p524"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Piazzini</surname><given-names>DB</given-names></name><name><surname>Aprile</surname><given-names>I</given-names></name><name><surname>Ferrara</surname><given-names>PE</given-names></name><name><surname>Bertolini</surname><given-names>C</given-names></name><name><surname>Tonali</surname><given-names>P</given-names></name><name><surname>Maggi</surname><given-names>L</given-names></name><etal/></person-group><article-title>A systematic review of conservative treatment of carpal tunnel syndrome</article-title><source>Clin Rehabil</source><year>2007</year><volume>21(4)</volume><fpage>299</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">17613571</pub-id></element-citation></ref><ref id="b12-cln_69p524"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Piravej</surname><given-names>K</given-names></name><name><surname>Boonhong</surname><given-names>J</given-names></name></person-group><article-title>Effect of ultrasound thermotherapy in mild to moderate carpal tunnel syndrome</article-title><source>J&#x000a0;Med Assoc Thai</source><year>2004</year><volume>87( Suppl 2)</volume><fpage>100</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14971542</pub-id></element-citation></ref><ref id="b13-cln_69p524"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oztas</surname><given-names>O</given-names></name><name><surname>Turan</surname><given-names>B</given-names></name><name><surname>Bora</surname><given-names>I</given-names></name><name><surname>Karakaya</surname><given-names>MK</given-names></name></person-group><article-title>Ultrasound therapy effect in carpal tunnel syndrome</article-title><source>Arch. Phys Med. Rehabil</source><year>1998</year><volume>79(12)</volume><fpage>1540</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9862296</pub-id></element-citation></ref><ref id="b14-cln_69p524"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weiss</surname><given-names>AP</given-names></name><name><surname>Sachar</surname><given-names>K</given-names></name><name><surname>Gendreau</surname><given-names>M</given-names></name></person-group><article-title>Conservative management of carpal tunnel syndrome: a reexamination of steroid injection and splinting</article-title><source>J&#x000a0;Hand Surg Am</source><year>1994</year><volume>19(3)</volume><fpage>410</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8056967</pub-id></element-citation></ref><ref id="b15-cln_69p524"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burke</surname><given-names>DT</given-names></name><name><surname>Burke</surname><given-names>MM</given-names></name><name><surname>Stewart</surname><given-names>GW</given-names></name><name><surname>Cambr&#x000e9;</surname><given-names>A</given-names></name></person-group><article-title>Splinting for carpal tunnel syndrome: in search of the optimal angle</article-title><source>Arch Phys Med Rehabil</source><year>1994</year><volume>75(11)</volume><fpage>1241</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7979936</pub-id></element-citation></ref><ref id="b16-cln_69p524"><label>16</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Delisa</surname><given-names>JA</given-names></name><name><surname>McKenzie</surname><given-names>K</given-names></name><name><surname>Baran</surname><given-names>EM</given-names></name></person-group><article-title>Manual of nerve conduction velocity and somatosensory evoked potentials</article-title><year>1987</year><publisher-loc>Newyork</publisher-loc><publisher-name>Raven Press</publisher-name></element-citation></ref><ref id="b17-cln_69p524"><label>17</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Oh</surname><given-names>SJ</given-names></name></person-group><article-title>Clinical Elecromyography</article-title><source>Nerve Conduction Studies</source><edition>ed 2</edition><year>1993</year><publisher-loc>Baltimore</publisher-loc><publisher-name>Williams &#x00026; Wilkins</publisher-name></element-citation></ref><ref id="b18-cln_69p524"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levine</surname><given-names>DW</given-names></name><name><surname>Simmons</surname><given-names>BP</given-names></name><name><surname>Koris</surname><given-names>MJ</given-names></name><name><surname>Daltroy</surname><given-names>LH</given-names></name><name><surname>Hohl</surname><given-names>GG</given-names></name><name><surname>Fossel</surname><given-names>AH</given-names></name><etal/></person-group><article-title>A self-administered questionnaire for the assesment of severity of symptoms and functional status in carpal tunnel syndrome</article-title><source>J&#x000a0;Bone Joint Surg Am</source><year>1993</year><volume>75(11)</volume><fpage>1585</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">8245050</pub-id></element-citation></ref><ref id="b19-cln_69p524"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Becker</surname><given-names>J</given-names></name><name><surname>Nora</surname><given-names>DB</given-names></name><name><surname>Gomes</surname><given-names>I</given-names></name><name><surname>Stringari</surname><given-names>FF</given-names></name><name><surname>Seitensus</surname><given-names>R</given-names></name><name><surname>Panosso</surname><given-names>JS</given-names></name><etal/></person-group><article-title>An evaluation of gender. obesity. age and diabetes mellitus as risk factors for carpal tunnel syndrome</article-title><source>Clin Neurophysiol</source><year>2002</year><volume>113(9)</volume><fpage>1429</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12169324</pub-id></element-citation></ref><ref id="b20-cln_69p524"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manente</surname><given-names>G</given-names></name><name><surname>Torrieri</surname><given-names>F</given-names></name><name><surname>Di Blasio</surname><given-names>F</given-names></name><name><surname>Staniscia</surname><given-names>T</given-names></name><name><surname>Romano</surname><given-names>F</given-names></name><name><surname>Uncini</surname><given-names>A</given-names></name></person-group><article-title>An innovative hand brace for carpal tunnel syndrome: a randomised controlled trial</article-title><source>Muscle Nerve</source><year>2001</year><volume>24(8)</volume><fpage>1020</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11439376</pub-id></element-citation></ref><ref id="b21-cln_69p524"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Premoselli</surname><given-names>S</given-names></name><name><surname>Sioli</surname><given-names>P</given-names></name><name><surname>Grossi</surname><given-names>A</given-names></name><name><surname>Cerri</surname><given-names>C</given-names></name></person-group><article-title>Neutral wrist splinting in carpal tunnel syndrome: a 3 and 6 month clinical and neurophysiologic followup evaluation of nightonly Splint therapy</article-title><source>Eura Medicophys</source><year>2006</year><volume>42(2)</volume><fpage>121</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16767058</pub-id></element-citation></ref><ref id="b22-cln_69p524"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bakhtiary</surname><given-names>AH</given-names></name><name><surname>Rashidy-Pour</surname><given-names>A</given-names></name></person-group><article-title>Ultrasoundand laser therapy in the treatment of carpal tunnel syndrome</article-title><source>Aust&#x000a0;J&#x000a0;Physiother</source><year>2004</year><volume>50(3)</volume><fpage>147</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15482245</pub-id></element-citation></ref><ref id="b23-cln_69p524"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>L</given-names></name></person-group><article-title>Nonpharmacologic management of osteoarthritis</article-title><source>Curr Opin Rheumatol</source><year>2002</year><volume>14(5)</volume><fpage>603</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">12192263</pub-id></element-citation></ref><ref id="b24-cln_69p524"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yildiz</surname><given-names>N</given-names></name><name><surname>Atalay</surname><given-names>NS</given-names></name><name><surname>Gungen</surname><given-names>GO</given-names></name><name><surname>Sanal</surname><given-names>E</given-names></name><name><surname>Akkaya</surname><given-names>N</given-names></name><name><surname>Topuz</surname><given-names>O</given-names></name></person-group><article-title>Comparison of ultrasound and ketoprofen phonophoresis in the treatment of carpal tunnel syndrome</article-title><source>J&#x000a0;Back Musculoskeletal Rehabil</source><year>2011</year><volume>24(1)</volume><fpage>39</fpage><lpage>47</lpage></element-citation></ref><ref id="b25-cln_69p524"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ekim</surname><given-names>A</given-names></name><name><surname>&#x000c7;olak</surname><given-names>E</given-names></name></person-group><article-title>Ultrasound Treatment in Carpal Tunnel Syndrome: A Placebo Controlled Study</article-title><source>Turk&#x000a0;J&#x000a0;Phys Med Rehab</source><year>2008</year><volume>54</volume><fpage>96</fpage><lpage>101</lpage></element-citation></ref><ref id="b26-cln_69p524"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dincer</surname><given-names>U</given-names></name><name><surname>Cakar</surname><given-names>E</given-names></name><name><surname>Kiralp</surname><given-names>MZ</given-names></name><name><surname>Kilac</surname><given-names>H</given-names></name><name><surname>Dursun</surname><given-names>H</given-names></name></person-group><article-title>The effectiveness of conservative treatments of carpal tunnel syndrome: splinting, ultrasound, and low-level laser therapies</article-title><source>Photomed Laser Surg</source><year>2009</year><volume>27(1)</volume><fpage>119</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">19196106</pub-id></element-citation></ref><ref id="b27-cln_69p524"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Currier</surname><given-names>DP</given-names></name><name><surname>Greathouse</surname><given-names>D</given-names></name><name><surname>Swift</surname><given-names>T</given-names></name></person-group><article-title>Sensory nerve conduction: effect of ultrasound</article-title><source>Arch Phys Med Rehabil</source><year>1978</year><volume>59(4)</volume><fpage>181</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">646607</pub-id></element-citation></ref><ref id="b28-cln_69p524"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El Hang</surname><given-names>M</given-names></name><name><surname>Coghlan</surname><given-names>K</given-names></name><name><surname>Christmas</surname><given-names>P</given-names></name><name><surname>Harvey</surname><given-names>W</given-names></name><name><surname>Haris</surname><given-names>M</given-names></name></person-group><article-title>The antiinflammatory effect of dexamethasone and therapeutic ultrasound in oral surgery</article-title><source>Br&#x000a0;J&#x000a0;Oral Maxillofac Surg</source><year>1985</year><volume>23(1)</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">3156621</pub-id></element-citation></ref><ref id="b29-cln_69p524"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hong</surname><given-names>CZ</given-names></name><name><surname>Liu</surname><given-names>HH</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>Ultrasound thermotherapy effect on the recovery of nerve conduction in experimental compression neuropathy</article-title><source>Arch Phys Med Rehabi</source><year>1988</year><volume>69(6)</volume><fpage>410</fpage><lpage>4</lpage></element-citation></ref><ref id="b30-cln_69p524"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kramer</surname><given-names>JF</given-names></name></person-group><article-title>Effect of therapeutic ultrasound intensity on subcutaneous tissue temperature and ulnar nerve conduction velocity</article-title><source>Am&#x000a0;J&#x000a0;Phys Med</source><year>1989</year><volume>64(1)</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3970155</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-cln_69p524" position="float"><label>Table 1</label><caption><p>Demographic characteristics of the patients.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Group 1 (n&#x0200a;=&#x0200a;15)Mean &#x000b1; SD</td><td align="center" valign="top" rowspan="1" colspan="1">Group 2 (n&#x0200a;=&#x0200a;16)Mean &#x000b1; SD</td><td align="center" valign="top" rowspan="1" colspan="1">Group 3 (n&#x0200a;=&#x0200a;15)Mean &#x000b1; SD</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Age (years)</bold></td><td align="center" valign="top" rowspan="1" colspan="1">45.20&#x000b1;2.98</td><td align="center" valign="top" rowspan="1" colspan="1">43.31&#x000b1;2.79</td><td align="center" valign="top" rowspan="1" colspan="1">44.53&#x000b1;2.38</td><td align="center" valign="top" rowspan="1" colspan="1">0.883</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Duration of symptoms (months)</bold></td><td align="center" valign="top" rowspan="1" colspan="1">13.67&#x000b1;3.52</td><td align="center" valign="top" rowspan="1" colspan="1">12.00&#x000b1;3.29</td><td align="center" valign="top" rowspan="1" colspan="1">11.87&#x000b1;2.70</td><td align="center" valign="top" rowspan="1" colspan="1">0.908</td></tr></tbody></table></table-wrap><table-wrap id="t2-cln_69p524" position="float"><label>Table 2</label><caption><p>Comparison of the clinical parameters at baseline and at the end of treatment (post-treatment).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Group 1Mean &#x000b1; SD(n&#x0200a;=&#x0200a;15)</td><td align="center" valign="top" rowspan="1" colspan="1">Group 2Mean &#x000b1; SD(n&#x0200a;=&#x0200a;16)</td><td align="center" valign="top" rowspan="1" colspan="1">Group 3Mean &#x000b1; SD(n&#x0200a;=&#x0200a;15)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>FSS</bold>
<bold>Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">21.33&#x000b1;7.37</td><td align="center" valign="top" rowspan="1" colspan="1">24.00&#x000b1;5.58</td><td align="center" valign="top" rowspan="1" colspan="1">19.00&#x000b1;0.85</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0</bold>.<bold>019</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post-treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">18.80&#x000b1;7.34</td><td align="center" valign="top" rowspan="1" colspan="1">19.31&#x000b1;9.42</td><td align="center" valign="top" rowspan="1" colspan="1">14.20&#x000b1;4.52</td><td align="center" valign="top" rowspan="1" colspan="1">0.125</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x02003;</bold><bold><italic>p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0</bold>.<bold>036</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0</bold>.<bold>041</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0</bold>.<bold>003</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>SSS</bold>
<bold>Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">26.60&#x000b1;8.11</td><td align="center" valign="top" rowspan="1" colspan="1">29.75&#x000b1;7.71</td><td align="center" valign="top" rowspan="1" colspan="1">25.93&#x000b1;4.46</td><td align="center" valign="top" rowspan="1" colspan="1">0.274</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post-treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">23.06&#x000b1;8.13</td><td align="center" valign="top" rowspan="1" colspan="1">22.06&#x000b1;8.73</td><td align="center" valign="top" rowspan="1" colspan="1">19.66&#x000b1;4.60</td><td align="center" valign="top" rowspan="1" colspan="1">0.442</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x02003;</bold><bold><italic>p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0</bold>.<bold>047</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0</bold>.<bold>002</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0</bold>.<bold>001</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>VAS</bold>
<bold>Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">5.40&#x000b1;2.32</td><td align="center" valign="top" rowspan="1" colspan="1">5.56&#x000b1;1.75</td><td align="center" valign="top" rowspan="1" colspan="1">5.20&#x000b1;1.26</td><td align="center" valign="top" rowspan="1" colspan="1">0.859</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post-treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">4.40&#x000b1;2.32</td><td align="center" valign="top" rowspan="1" colspan="1">2.68&#x000b1;1.92</td><td align="center" valign="top" rowspan="1" colspan="1">3.53&#x000b1;1.95</td><td align="center" valign="top" rowspan="1" colspan="1">0.083</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x02003;</bold><bold><italic>p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.006</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.000</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.003</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn1-cln_69p524"><p><bold>FSS:</bold> Functional Status Scale.</p></fn><fn id="tfn2-cln_69p524"><p><bold>SSS:</bold> Symptom Severity Scale.</p></fn><fn id="tfn3-cln_69p524"><p><bold>VAS:</bold> Visual Analogue Scale.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-cln_69p524" position="float"><label>Table 3</label><caption><p>Comparison of electrophysiological parameters at baseline and at the end of the treatment (post-treatment).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Group 1Mean &#x000b1; SD(n&#x0200a;=&#x0200a;15)</td><td align="center" valign="top" rowspan="1" colspan="1">Group 2Mean &#x000b1; SD(n&#x0200a;=&#x0200a;16)</td><td align="center" valign="top" rowspan="1" colspan="1">Group 3Mean &#x000b1; SD(n&#x0200a;=&#x0200a;15)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Motor NCV</bold>
<bold>Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">53.82&#x000b1;4.10</td><td align="center" valign="top" rowspan="1" colspan="1">56.15&#x000b1;4.44</td><td align="center" valign="top" rowspan="1" colspan="1">58.05&#x000b1;6.43</td><td align="center" valign="top" rowspan="1" colspan="1">0.086</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post-treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">54.26&#x000b1;4.29</td><td align="center" valign="top" rowspan="1" colspan="1">55.68&#x000b1;5.24</td><td align="center" valign="top" rowspan="1" colspan="1">57.91&#x000b1;5.44</td><td align="center" valign="top" rowspan="1" colspan="1">0.146</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x02003;</bold><bold><italic>p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1">0.705</td><td align="center" valign="top" rowspan="1" colspan="1">0.766</td><td align="center" valign="top" rowspan="1" colspan="1">0.943</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>SDL (digit II to palm)</bold>
<bold>Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">3.50&#x000b1;0.72</td><td align="center" valign="top" rowspan="1" colspan="1">3.46&#x000b1;0.68</td><td align="center" valign="top" rowspan="1" colspan="1">3.45&#x000b1;0.58</td><td align="center" valign="top" rowspan="1" colspan="1">0.979</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post-treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">3.49&#x000b1;0.96</td><td align="center" valign="top" rowspan="1" colspan="1">3.51&#x000b1;0.61</td><td align="center" valign="top" rowspan="1" colspan="1">3.25&#x000b1;0.69</td><td align="center" valign="top" rowspan="1" colspan="1">0.605</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x02003;</bold><bold><italic>p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1">0.911</td><td align="center" valign="top" rowspan="1" colspan="1">0.506</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.011</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>SDL (palm to wrist) Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">2.76&#x000b1;0.55</td><td align="center" valign="top" rowspan="1" colspan="1">2.75&#x000b1;0.55</td><td align="center" valign="top" rowspan="1" colspan="1">2.79&#x000b1;0.60</td><td align="center" valign="top" rowspan="1" colspan="1">0.318</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post-treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">2.76&#x000b1;0.72</td><td align="center" valign="top" rowspan="1" colspan="1">2.65&#x000b1;0.62</td><td align="center" valign="top" rowspan="1" colspan="1">2.84&#x000b1;0.57</td><td align="center" valign="top" rowspan="1" colspan="1">0.912</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x02003;</bold><bold><italic>p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.042</bold></td><td align="center" valign="top" rowspan="1" colspan="1">0.336</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Distal motor latency</bold>
<bold>Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">4.17&#x000b1;0.70</td><td align="center" valign="top" rowspan="1" colspan="1">4.20&#x000b1;0.90</td><td align="center" valign="top" rowspan="1" colspan="1">4.60&#x000b1;1.23</td><td align="center" valign="top" rowspan="1" colspan="1">0.403</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post-treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">4.19&#x000b1;0.82</td><td align="center" valign="top" rowspan="1" colspan="1">4.17&#x000b1;0.086</td><td align="center" valign="top" rowspan="1" colspan="1">4.45&#x000b1;1.37</td><td align="center" valign="top" rowspan="1" colspan="1">0.714</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic>&#x02003;p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1">0.889</td><td align="center" valign="top" rowspan="1" colspan="1">0.725</td><td align="center" valign="top" rowspan="1" colspan="1">0.271</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>SNCV(digit II to palm)</bold>
<bold>Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">32.74&#x000b1;5.29</td><td align="center" valign="top" rowspan="1" colspan="1">33.13&#x000b1;4.79</td><td align="center" valign="top" rowspan="1" colspan="1">32.26&#x000b1;7.51</td><td align="center" valign="top" rowspan="1" colspan="1">0.922</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post-treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">33.76&#x000b1;6.75</td><td align="center" valign="top" rowspan="1" colspan="1">32.53&#x000b1;4.61</td><td align="center" valign="top" rowspan="1" colspan="1">33.32&#x000b1;7.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.866</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x02003;</bold><bold><italic>p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1">0.214</td><td align="center" valign="top" rowspan="1" colspan="1">0.479</td><td align="center" valign="top" rowspan="1" colspan="1">0.101</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>SNCV (palm to wrist) Baseline</bold></td><td align="center" valign="top" rowspan="1" colspan="1">25.46&#x000b1;6.75</td><td align="center" valign="top" rowspan="1" colspan="1">26.28&#x000b1;4.17</td><td align="center" valign="top" rowspan="1" colspan="1">27.04&#x000b1;5.65</td><td align="center" valign="top" rowspan="1" colspan="1">0.743</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Post treatment</bold></td><td align="center" valign="top" rowspan="1" colspan="1">26.82&#x000b1;6.25</td><td align="center" valign="top" rowspan="1" colspan="1">29.66&#x000b1;6.09</td><td align="center" valign="top" rowspan="1" colspan="1">32.03&#x000b1;6.84</td><td align="center" valign="top" rowspan="1" colspan="1">0.094</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x02003;</bold><bold><italic>p</italic></bold><bold>-value</bold></td><td align="center" valign="top" rowspan="1" colspan="1">0.203</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.008</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.003</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn4-cln_69p524"><p><bold>SNCV:</bold> Sensory nerve conduction velocity.</p></fn><fn id="tfn5-cln_69p524"><p><bold>SDL:</bold> Sensory distal latency.</p></fn></table-wrap-foot></table-wrap></floats-group></article>